NCT00729326 - Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

exenatide

subcutaneous injection (5mcg or 10mcg), twice a day

DRUG

sitagliptin

oral administration (100mg), once a day in the morning

DRUG

placebo

subcutaneous injection (5mcg or 10mcg), twice a day

DRUG

placebo

oral administration (100mg), once a day in the morning

Trial Locations (1)

Research Site, San Antonio